Atlas FDA

IMPAX Cardiovascular Results Management (RM) Software Versions RM 2.04.37.04 to RM 7.8 SU2 The IMPAX Cardiovascular suit

FDA device recall Z-0211-2012 · posted 2011-11-18 · Terminated

Recall details

Recalling firm
AGFA Corp.
Reason for recall
Improper merging of IMPAX Cardiovascular Results Management (RM) reports causes the signed report to become unavailable.
Action taken
AGFA Healthcare sent an "URGENT FIELD SAFETY NOTICE" letter dated May 27, 2011, via Fed Ex to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed not to carry out a merge post finalization of an RM reports. If it is necessary to modify a finalized report, AGFA recommends that they make the modification through one of the following actions: Amend the report through the RM interface, or Call AGFA Service to change the status of the report to "preliminary" and then proceed with the finalization of the report. AGFA issued an Acknowledgment, via FAX- Back that the information was received and understood to affected customers. For any questions customers were instructed to contact their AGFA Healthcare Service at 877-777-2432.
Root cause
Software design
Status
Terminated
Product code
LLZ
Quantity affected
323
Distribution
Worldwide Distribution - USA (nationwide) and Canada
Date initiated
2011-06-06
Date posted
2011-11-18
Date terminated
2013-07-02
Location
Greenville, SC

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
AGFA HEARTLAB CARDIOVASCULAR (K050228)Heartlab, Inc.2005-02-18